[go: up one dir, main page]

GB202112820D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB202112820D0
GB202112820D0 GBGB2112820.2A GB202112820A GB202112820D0 GB 202112820 D0 GB202112820 D0 GB 202112820D0 GB 202112820 A GB202112820 A GB 202112820A GB 202112820 D0 GB202112820 D0 GB 202112820D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2112820.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spepharm AG
Original Assignee
Spepharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spepharm AG filed Critical Spepharm AG
Priority to GBGB2112820.2A priority Critical patent/GB202112820D0/en
Publication of GB202112820D0 publication Critical patent/GB202112820D0/en
Priority to PCT/EP2022/062307 priority patent/WO2022234100A1/en
Priority to MX2023013033A priority patent/MX2023013033A/en
Priority to CA3215559A priority patent/CA3215559A1/en
Priority to US18/559,213 priority patent/US20240245653A1/en
Priority to IL308250A priority patent/IL308250A/en
Priority to EP22726764.8A priority patent/EP4333806A1/en
Priority to CN202280033163.2A priority patent/CN117279625A/en
Priority to AU2022269311A priority patent/AU2022269311A1/en
Priority to JP2023568491A priority patent/JP2024516464A/en
Priority to BR112023023081A priority patent/BR112023023081A2/en
Priority to KR1020237041670A priority patent/KR20240007191A/en
Ceased legal-status Critical Current

Links

GBGB2112820.2A 2021-05-06 2021-09-08 Pharmaceutical formulations Ceased GB202112820D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2112820.2A GB202112820D0 (en) 2021-09-08 2021-09-08 Pharmaceutical formulations
KR1020237041670A KR20240007191A (en) 2021-05-06 2022-05-06 pharmaceutical preparation
US18/559,213 US20240245653A1 (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
MX2023013033A MX2023013033A (en) 2021-05-06 2022-05-06 Pharmaceutical formulations.
CA3215559A CA3215559A1 (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
PCT/EP2022/062307 WO2022234100A1 (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
IL308250A IL308250A (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
EP22726764.8A EP4333806A1 (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
CN202280033163.2A CN117279625A (en) 2021-05-06 2022-05-06 Pharmaceutical preparation
AU2022269311A AU2022269311A1 (en) 2021-05-06 2022-05-06 Pharmaceutical formulations
JP2023568491A JP2024516464A (en) 2021-05-06 2022-05-06 Pharmaceutical preparations
BR112023023081A BR112023023081A2 (en) 2021-05-06 2022-05-06 PHARMACEUTICAL FORMULATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2112820.2A GB202112820D0 (en) 2021-09-08 2021-09-08 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB202112820D0 true GB202112820D0 (en) 2021-10-20

Family

ID=78076886

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2112820.2A Ceased GB202112820D0 (en) 2021-05-06 2021-09-08 Pharmaceutical formulations

Country Status (2)

Country Link
CN (1) CN117279625A (en)
GB (1) GB202112820D0 (en)

Also Published As

Publication number Publication date
CN117279625A (en) 2023-12-22

Similar Documents

Publication Publication Date Title
GB202008961D0 (en) Pharmaceutical composition
SG11202109102PA (en) Pharmaceutical formulations
GB202010230D0 (en) Pharmaceutical formulation
ZA202006570B (en) Pharmaceutical formulations
IL290894A (en) Pharmaceutical formulation
GB202005282D0 (en) Pharmaceutical Formulations
SG11202010792TA (en) Improved pharmaceutical formulations
GB201906473D0 (en) Pharmaceutical formulation
IL297080A (en) Pharmaceutical formulation
IL297081A (en) Pharmaceutical formulation
GB202001439D0 (en) Drug formulations
GB202100526D0 (en) Pharmaceutical formulation
IL300090A (en) Pharmaceutical compositions comprising venglustat
IL307803A (en) Pharmaceutical hydronidone formulations for diseases
GB202019335D0 (en) Pharmaceutical compositions
GB202018889D0 (en) Formulations
GB202018068D0 (en) Pharmaceutical composition
GB202009684D0 (en) Formulations
ZA202212663B (en) Pharmaceutical formulations
IL308250A (en) Pharmaceutical formulations
GB202112820D0 (en) Pharmaceutical formulations
GB202003108D0 (en) Pharmaceutical formulations
GB202307626D0 (en) Pharmaceutical formulations
GB202015273D0 (en) Solid form pharmaceutical formulations
HK40100860A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)